The Essential Medicinal Chemistry of Curcumin
Open accessThe DOI matches its Crossref record; 151 of the 153 references it cites were found in a registry or an index.
Abstract
Curcumin is a constituent (up to ∼5%) of the traditional medicine known as turmeric. Interest in the therapeutic use of turmeric and the relative ease of isolation of curcuminoids has led to their extensive investigation. Curcumin has recently been classified as both a PAINS (pan-assay interference compounds) and an IMPS (invalid metabolic panaceas) candidate. The likely false activity of curcumin in vitro and in vivo has resulted in >120 clinical trials of curcuminoids against several diseases. No double-blinded, placebo controlled clinical trial of curcumin has been successful. This manuscript reviews the essential medicinal chemistry of curcumin and provides evidence that curcumin is an unstable, reactive, nonbioavailable compound and, therefore, a highly improbable lead. On the basis of this in-depth evaluation, potential new directions for research on curcuminoids are discussed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“One mechanism by which polyphenols could exert protective properties is by generation of a hormetic response to their use85–88.”
From Oxidative stress, dysfunctional glucose metabolism and Alzheimer disease (2019) · cites this paper as [88]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“In vivo use of polyphenols (especially curcumin) in some mouse models of AD has been successful77,87, but this has not (yet) been translated to usefulness in human AD2,70,87,88.”
From Oxidative stress, dysfunctional glucose metabolism and Alzheimer disease (2019) · cites this paper as [88]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
6 retracted
Tomita, M., Kawakami, H., Uchihara, J., Okudaira, T., Masuda, M., Takasu, N., Matsuda, T., Ohta, T., Tanaka, Y., & Mori, N. (2005) · Leukemia Research · doi:10.1016/j.leukres.2005.08.004 · Cited by 55
RetractedKundu, P., Mohanty, C., & Sahoo, S. K. (2012) · Acta Biomaterialia · doi:10.1016/j.actbio.2012.03.048 · Cited by 51
RetractedDilnawaz, F., Singh, A., & Sahoo, S. K. (2011) · Acta Biomaterialia · doi:10.1016/j.actbio.2011.10.022 · Cited by 33
RetractedSeely, K. A., Levi, M. S., & Prather, P. L. (2009) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.109.151654 · Cited by 21
RetractedNi, Z., Xing, F., Wang, P., & Cao, G. (2007) · Applied Clay Science · doi:10.1016/j.clay.2007.07.008 · Cited by 20
RetractedPrather, P. L., Seely, K. A., & Levi, M. S. (2009) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)45583-3 · Cited by 3
RetractedGlutamate neurotoxicity and diseases of the nervous system
CHOI, D. (1988) · Neuron · doi:10.1016/0896-6273(88)90162-6 · Cited by 7,972
Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis
Kayed, R., Head, E., Thompson, J. L., McIntire, T. M., Milton, S. C., Cotman, C. W., & Glabe, C. G. (2003) · Science · doi:10.1126/science.1079469 · Cited by 4,064 · cited 1×
“136 However, the extremely long incubation times reported here would require follow-up to exclude the likely possibility of aggregation or degradation in the assay conditions.”
Baell, J. B., & Holloway, G. A. (2010) · Journal of Medicinal Chemistry · doi:10.1021/jm901137j · Cited by 3,944
Discovery and resupply of pharmacologically active plant-derived natural products: A review
Atanasov, A. G., Waltenberger, B., Pferschy-Wenzig, E.-M., Linder, T., Wawrosch, C., Uhrin, P., Temml, V., Wang, L., Schwaiger, S., Heiss, E. H., et al. (2015) · Biotechnology Advances · doi:10.1016/j.biotechadv.2015.08.001 · Cited by 2,904
Research works printed but not linked: 4
- 2. Hanson M. Is the 2015 Nobel Prize a turning point for traditional Chinese medicine? https://theconversation.com/is-the-2015-nobel-prize-a-turning-point-for-traditional-chinese-medicine-48643 (accessed June 6, 2016). · DOI
- 10. Elias G.; Jacob P. J.; Hareeshbabu E.; Mathew V. B.; Krishnan B.; Krishnakumar K. Curcumin: Transforming the spice to a wonder drug. Int. J. Pharm. Sci. Res. 2015, 6, 2671– 2680. 10.13040/IJPSR.0975-8232.6(7).2671-80. · doi:10.13040/ijpsr.0975-8232.6(7).2671-80
- 35. Majeed S. The state of the curcumin market. Natural Products Insider; Informa Exhibitions, 2015; http://www.naturalproductsinsider.com/articles/2015/12/the-state-of-the-curcumin-market.aspx.
- 36. Niranjan A.; Prakash D. Chemical constituents and biological activities of turmeric (Curcuma longa l.) - a review. J. Food Sci. Technol. (New Delhi, India) 2008, 45, 109– 116.
Cited by
Reactive Oxygen Species, Toxicity, Oxidative Stress, and Antioxidants: Chronic Diseases and Aging
Jomova, K., Raptova, R., Alomar, S. Y., Alwasel, S. H., Nepovimova, E., Kuca, K., & Valko, M. (2023) · Archives of Toxicology · doi:10.1007/s00204-023-03562-9 · Cited by 2,638
Oxidative stress, dysfunctional glucose metabolism and Alzheimer disease
Butterfield, D. A., & Halliwell, B. (2019) · Nature Reviews Neuroscience · doi:10.1038/s41583-019-0132-6 · Cited by 1,954
Curcumin: Biological, Pharmaceutical, Nutraceutical, and Analytical Aspects
Kotha, R. R., & Luthria, D. L. (2019) · Molecules · doi:10.3390/molecules24162930 · Cited by 890
“Pure CUR has been used in many in vitro studies, whereas most in vivo studies and clinical trials use CCMs mixture [24].”
BackgroundMethodInfluentialSharifi-Rad, J., Rayess, Y. E., Rizk, A. A., Sadaka, C., Zgheib, R., Zam, W., Sestito, S., Rapposelli, S., Neffe-Skocińska, K., Zielińska, D., et al. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.01021 · Cited by 937
“On the other hand, curcumin seems to offer a promising potential for the therapeutic development from turmeric, categorized as a Generally Recognized As Safe (GRAS) material, with a stable metabolism and low toxicity (Nelson et al., 2017).”
BackgroundInfluentialAnand, U., Jacobo-Herrera, N., Altemimi, A., & Lakhssassi, N. (2019) · Metabolites · doi:10.3390/metabo9110258 · Cited by 867
“It is sold in the market in many forms such as herbal supplements, food additives to increase flavour and aroma, cosmetics ingredients, and as a colouring agent in many food items [72].”
BackgroundPolyphenols: A concise overview on the chemistry, occurrence, and human health
Durazzo, A., Lucarini, M., Souto, E. B., Cicala, C., Caiazzo, E., Izzo, A. A., Novellino, E., & Santini, A. (2019) · Phytotherapy Research · doi:10.1002/ptr.6419 · Cited by 802
“Curcumin, which represents by alone a constituent (up to ∼5%) of the traditional olistic medicine, is known as turmeric (Nakmareong et al., 2011; Nelson et al., 2017).”
BackgroundNanotechnologies in Food Science: Applications, Recent Trends, and Future Perspectives
Nile, S. H., Baskar, V., Selvaraj, D., Nile, A., Xiao, J., & Kai, G. (2020) · Nano-Micro Letters · doi:10.1007/s40820-020-0383-9 · Cited by 631
Risk factors and prevention of hepatocellular carcinoma in the era of precision medicine
Fujiwara, N., Friedman, S. L., Goossens, N., & Hoshida, Y. (2018) · Journal of Hepatology · doi:10.1016/j.jhep.2017.09.016 · Cited by 659
Dietary Curcumin: Correlation between Bioavailability and Health Potential
Dei Cas, M., & Ghidoni, R. (2019) · Nutrients · doi:10.3390/nu11092147 · Cited by 589
“In Curcuma longa, crude extract curcuminoid makes up 1–6% of turmeric by weight, distributed in 60–70% curcumin, 20–27% demethoxycurcumin, and 10–15% bis-demethoxycurcumin [6] whereas commercially available curcumin contains about 77% in curcuminoids [2].”
BackgroundEpigenetic regulation in metabolic diseases: mechanisms and advances in clinical study
Wu, Y.-L., Lin, Z.-J., Li, C.-C., Lin, X., Shan, S.-K., Guo, B., Zheng, M.-H., Li, F., Yuan, L.-Q., & Li, Z.-H. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01333-7 · Cited by 476
“Curcumin is isolated from turmeric, a traditional Chinese medicine.(404) Curcumin suppresses FOXO1 acetylation and ameliorates DCM by reducing oxidative stress and inhibiting cardiomyocyte apoptosis.”
BackgroundHuman Gut Microbiota and Gastrointestinal Cancer
Meng, C., Bai, C., Brown, T. D., Hood, L. E., & Tian, Q. (2018) · Genomics, Proteomics & Bioinformatics · doi:10.1016/j.gpb.2017.06.002 · Cited by 467
“However, numerous clinical studies assessing the efficacy of curcumin in cancer treatment has been inconclusive [237].”
BackgroundNanocurcumin: A Promising Candidate for Therapeutic Applications
Karthikeyan, A., Senthil, N., & Min, T. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.00487 · Cited by 414
“Curcumin has three chemical substances: two aromatic ring systems of o-methoxy phenolic groups, linked by a seven-carbon connector comprising a a,b-unsaturated b-diketone moiety (Nelson et al., 2017).”
BackgroundThermoresponsive polymer nanocarriers for biomedical applications
Bordat, A., Boissenot, T., Nicolas, J., & Tsapis, N. (2019) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2018.10.005 · Cited by 415
Abd El‐Hack, M. E., El‐Saadony, M. T., Swelum, A. A., Arif, M., Abo Ghanima, M. M., Shukry, M., Noreldin, A., Taha, A. E., & El‐Tarabily, K. A. (2021) · Journal of the Science of Food and Agriculture · doi:10.1002/jsfa.11372 · Cited by 392
Lopresti, A. L. (2018) · Advances in Nutrition · doi:10.1093/advances/nmx011 · Cited by 371
Curcumin: Biological Activities and Modern Pharmaceutical Forms
Urošević, M., Nikolić, L., Gajić, I., Nikolić, V., Dinić, A., & Miljković, V. (2022) · Antibiotics · doi:10.3390/antibiotics11020135 · Cited by 347
“Curcumin (1,7-bis-(4-hydroxy-3-methoxyphenyl)-1,6-heptadiene-3,5-dione) [43] or diferuloylmethane [44] is an integral component of turmeric (up to ~5%), a well-known traditional spice [45].”
BackgroundTsuda, T. (2018) · Food & Function · doi:10.1039/c7fo01242j · Cited by 367
Xu, X.-Y., Meng, X., Li, S., Gan, R.-Y., Li, Y., & Li, H.-B. (2018) · Nutrients · doi:10.3390/nu10101553 · Cited by 358
“The extract of turmeric contains three major curcuminoids (Figure 1): Curcumin (60–70%), demethoxycurcumin (20–27%), and bisdemethoxycurcumin (10–15%) [2].”
BackgroundZheng, B., & McClements, D. J. (2020) · Molecules · doi:10.3390/molecules25122791 · Cited by 344
“The bioaccessibility of the curcumin in the emulsions was determined using an in vitro model, and shown to be higher than non-encapsulated curcumin, as well as commercial curcumin supplements [55].”
BackgroundMethodThe Natural Product Curcumin as an Antibacterial Agent: Current Achievements and Problems
Dai, C., Lin, J., Li, H., Shen, Z., Wang, Y., Velkov, T., & Shen, J. (2022) · Antioxidants · doi:10.3390/antiox11030459 · Cited by 318
Oxidative stress in the eye and its role in the pathophysiology of ocular diseases
Böhm, E. W., Buonfiglio, F., Voigt, A. M., Bachmann, P., Safi, T., Pfeiffer, N., & Gericke, A. (2023) · Redox Biology · doi:10.1016/j.redox.2023.102967 · Cited by 301
“Curcumin, an inherent constituent of turmeric spice with deep-rooted applications in traditional medicine, has been the focus of numerous investigations [458].”
BackgroundAung, T., Qu, Z., Kortschak, R., & Adelson, D. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18030656 · Cited by 319
“While many researchers are optimistic regarding curcumin’s potential effectiveness against cancer, there is evidence to show that curcumin has no therapeutic benefits despite many published articles and clinical trials [67].”
BackgroundThe Mechanisms of Action of Curcumin in Alzheimer’s Disease
Tang, M., & Taghibiglou, C. (2017) · Journal of Alzheimer’s Disease · doi:10.3233/jad-170188 · Cited by 304
“[108] argues that curcumin exerts false activity in vitro and in vivo due to its classification as a pan-assay interference compound (PAIN).”
Application of different nanocarriers for encapsulation of curcumin
Rafiee, Z., Nejatian, M., Daeihamed, M., & Jafari, S. M. (2019) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2018.1495174 · Cited by 300
“secondary metabolites accumulated in rhizomes (Nelson et al. 2017).”
BackgroundMcCubrey, J. A., Lertpiriyapong, K., Steelman, L. S., Abrams, S. L., Yang, L. V., Murata, R. M., Rosalen, P. L., Scalisi, A., Neri, L. M., Cocco, L., et al. (2017) · Aging · doi:10.18632/aging.101250 · Cited by 285
“CUR has been suggested to lack the properties required to be a good drug candidate [201].”
BackgroundAbrahams, S., Haylett, W. L., Johnson, G., Carr, J. A., & Bardien, S. (2019) · Neuroscience · doi:10.1016/j.neuroscience.2019.02.020 · Cited by 297
Desai, S. J., Prickril, B., & Rasooly, A. (2018) · Nutrition and Cancer · doi:10.1080/01635581.2018.1446091 · Cited by 274
“an IMPS (invalid metabolic panaceas) candidate (27,28); however, this designation was questioned (124).”
BackgroundGou, S., Huang, Y., Wan, Y., Ma, Y., Zhou, X., Tong, X., Huang, J., Kang, Y., Pan, G., Dai, F., et al. (2019) · Biomaterials · doi:10.1016/j.biomaterials.2019.05.012 · Cited by 277
Natural Products from Herbal Medicine Self‐Assemble into Advanced Bioactive Materials
Guo, X., Luo, W., Wu, L., Zhang, L., Chen, Y., Li, T., Li, H., Zhang, W., Liu, Y., Zheng, J., et al. (2024) · Advanced Science · doi:10.1002/advs.202403388 · Cited by 240
Immunomodulators Inspired by Nature: A Review on Curcumin and Echinacea
Catanzaro, M., Corsini, E., Rosini, M., Racchi, M., & Lanni, C. (2018) · Molecules · doi:10.3390/molecules23112778 · Cited by 258
“To date, many limitations have been recognized for a therapeutic use of curcumin: its poor pharmacokinetic/pharmacodynamic properties, its chemical instability, its low efficacy in different in vitro and in vivo disease models, its toxic profile under certain experimental settings [53] and the very recently suggestion…”
BackgroundInfluentialTargeting Drug Chemo-Resistance in Cancer Using Natural Products
Talib, W. H., Alsayed, A. R., Barakat, M., Abu-Taha, M. I., & Mahmod, A. I. (2021) · Biomedicines · doi:10.3390/biomedicines9101353 · Cited by 231
Curcumin Nanoformulations for Colorectal Cancer: A Review
Wong, K. E., Ngai, S. C., Chan, K.-G., Lee, L.-H., Goh, B.-H., & Chuah, L.-H. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.00152 · Cited by 262
“CUR has been classified as both a PAINS (pan-assay interference compounds) and an IMPS (invalid metabolic panaceas) candidate by some researchers (Baell and Walters, 2014; Nelson et al., 2017).”
BackgroundCione, E., La Torre, C., Cannataro, R., Caroleo, M. C., Plastina, P., & Gallelli, L. (2019) · Molecules · doi:10.3390/molecules25010063 · Cited by 248
“Extensive metabolic reduction also occurs at enterocyte and hepatocyte levels leading to the formation of dihydrocurcumin, tetrahydrocurcumin, hexa-hydrocurcumin, and octahydrocurcumin which in turn are converted through conjugation into physiologically inactive constituents [163].”
BackgroundClinicians’ Guide to Cannabidiol and Hemp Oils
VanDolah, H. J., Bauer, B. A., & Mauck, K. F. (2019) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2019.01.003 · Cited by 236
Development of native and modified banana starch nanoparticles as vehicles for curcumin
Acevedo-Guevara, L., Nieto-Suaza, L., Sanchez, L. T., Pinzon, M. I., & Villa, C. C. (2018) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2018.01.063 · Cited by 246
Application of curcumin-loaded nanocarriers for food, drug and cosmetic purposes
Rafiee, Z., Nejatian, M., Daeihamed, M., & Jafari, S. M. (2019) · Trends in Food Science & Technology · doi:10.1016/j.tifs.2019.04.017 · Cited by 240
Li, Y., Zou, Q., Yuan, C., Li, S., Xing, R., & Yan, X. (2018) · Angewandte Chemie International Edition · doi:10.1002/anie.201810087 · Cited by 236
Chitosan-based nanocarriers for encapsulation and delivery of curcumin: A review
Hu, Q., & Luo, Y. (2021) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2021.02.216 · Cited by 230
Kunnumakkara, A. B., Hegde, M., Parama, D., Girisa, S., Kumar, A., Daimary, U. D., Garodia, P., Yenisetti, S. C., Oommen, O. V., & Aggarwal, B. B. (2023) · ACS Pharmacology & Translational Science · doi:10.1021/acsptsci.2c00012 · Cited by 201
Curcumin, Gut Microbiota, and Neuroprotection
Di Meo, F., Margarucci, S., Galderisi, U., Crispi, S., & Peluso, G. (2019) · Nutrients · doi:10.3390/nu11102426 · Cited by 214
Zhang, Y., Xia, Q., Li, Y., He, Z., Li, Z., Guo, T., Wu, Z., & Feng, N. (2019) · Theranostics · doi:10.7150/thno.29715 · Cited by 218
“In addition, in association with the in vitro release study results, the release of the drug from ES in the culture medium was more than that from HA-ES; this could also be because of the free curcumin molecules being photodegraded or the difficulty in their uptake by cells owing to the poor water solubility and low a…”
BackgroundLiposome-Encapsulated Curcumin-Loaded 3D Printed Scaffold for Bone Tissue Engineering
Sarkar, N., & Bose, S. (2019) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.9b01218 · Cited by 216
Larasati, Y. A., Yoneda-Kato, N., Nakamae, I., Yokoyama, T., Meiyanto, E., & Kato, J.-Y. (2018) · Scientific Reports · doi:10.1038/s41598-018-20179-6 · Cited by 209
Curcumin as an Antiviral Agent
Jennings, M. R., & Parks, R. J. (2020) · Viruses · doi:10.3390/v12111242 · Cited by 204
“However, curcumin has low bioavailability and is rapidly metabolized (reviewed in [82]), compromising curcumin’s effectiveness as an antiviral compound, and likely contributing to the limited success observed in human clinical trials [83].”
BackgroundJaja-Chimedza, A., Graf, B. L., Simmler, C., Kim, Y., Kuhn, P., Pauli, G. F., & Raskin, I. (2017) · PLOS ONE · doi:10.1371/journal.pone.0182658 · Cited by 199
Self-citationRecent advances to improve curcumin oral bioavailability
Sabet, S., Rashidinejad, A., Melton, L. D., & McGillivray, D. J. (2021) · Trends in Food Science & Technology · doi:10.1016/j.tifs.2021.02.006 · Cited by 207
Therapeutic Potential of Cannabidiol (CBD) for Skin Health and Disorders
Baswan, S. M., Klosner, A. E., Glynn, K., Rajgopal, A., Malik, K., Yim, S., & Stern, N. (2020) · Clinical, Cosmetic and Investigational Dermatology · doi:10.2147/ccid.s286411 · Cited by 187
Natural product-based amyloid inhibitors
Velander, P., Wu, L., Henderson, F., Zhang, S., Bevan, D. R., & Xu, B. (2017) · Biochemical Pharmacology · doi:10.1016/j.bcp.2017.04.004 · Cited by 202
“Because curcumin has been identified as a potential pan-assay interference compound (PAINS) [61], it is especially important to have multiple orthogonal assays to validate the bioactivities of curcumin.”
BackgroundInhalation treatment of primary lung cancer using liposomal curcumin dry powder inhalers
Zhang, T., Chen, Y., Ge, Y., Hu, Y., Li, M., & Jin, Y. (2018) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2018.03.004 · Cited by 203
Inchingolo, A. D., Inchingolo, A. M., Malcangi, G., Avantario, P., Azzollini, D., Buongiorno, S., Viapiano, F., Campanelli, M., Ciocia, A. M., De Leonardis, N., et al. (2022) · Nutrients · doi:10.3390/nu14173519 · Cited by 176
A review of dietary stilbenes: sources and bioavailability
El Khawand, T., Courtois, A., Valls, J., Richard, T., & Krisa, S. (2018) · Phytochemistry Reviews · doi:10.1007/s11101-018-9578-9 · Cited by 195
“This feature led to the classification of those types of compounds as pan assay interference compounds (PAINS) or invalid metabolic panaceas (IMPS) (Nelson et al. 2017).”
BackgroundTopical treatments for skin cancer
Cullen, J. K., Simmons, J. L., Parsons, P. G., & Boyle, G. M. (2020) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2019.11.002 · Cited by 191
Heidari, H., Bagherniya, M., Majeed, M., Sathyapalan, T., Jamialahmadi, T., & Sahebkar, A. (2023) · Phytotherapy Research · doi:10.1002/ptr.7737 · Cited by 181
“It has also been used in some hepatobiliary conditions and as an anthelminthic agent (Nelson et al., 2017).”
BackgroundKang, L., Liang, Q., Abdul, Q., Rashid, A., Ren, X., & Ma, H. (2023) · Food Chemistry · doi:10.1016/j.foodchem.2023.136142 · Cited by 185
Fu, H., Wang, C., Yang, D., Wei, Z., Xu, J., Hu, Z., Zhang, Y., Wang, W., Yan, R., & Cai, Q. (2018) · Journal of Cellular Physiology · doi:10.1002/jcp.26190 · Cited by 178
“(Nelson et al., 2017).”
Small molecules regulating reactive oxygen species homeostasis for cancer therapy
Zhang, J., Duan, D., Song, Z., Liu, T., Hou, Y., & Fang, J. (2021) · Medicinal Research Reviews · doi:10.1002/med.21734 · Cited by 184
“The reasons why 22 exerts protective effects may be due to the presence of the Michael acceptor group that makes 22 react with the cysteine sulfhydryl groups in Keap1 easily and then promotes the expression of the antioxidant enzymes Thus, 22 could act as an inducer of the Nrf2/ARE signaling pathway.(173,174) Due to t…”
BackgroundZhang, N., Yan, F., Liang, X., Wu, M., Shen, Y., Chen, M., Xu, Y., Zou, G., Jiang, P., Tang, C., et al. (2018) · Theranostics · doi:10.7150/thno.23734 · Cited by 178
Rizvi, S. A. A., Einstein, G. P., Tulp, O. L., Sainvil, F., & Branly, R. (2022) · Biomolecules · doi:10.3390/biom12101442 · Cited by 181
“The curcumin structure’s inclination increases its free radical scavenging activities to low-level hydrogenation and a high level of methoxylation [71].”
BackgroundBanerjee, S., Ji, C., Mayfield, J. E., Goel, A., Xiao, J., Dixon, J. E., & Guo, X. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1806797115 · Cited by 174
“Curcumin has been one of the most controversial yet extensively studied natural products over the past three decades, having been implicated in a wide range of diseases, often with contradictory results reported by various groups worldwide (6).”
BackgroundResultInfluentialTai, K., Rappolt, M., Mao, L., Gao, Y., Li, X., & Yuan, F. (2020) · Food Hydrocolloids · doi:10.1016/j.foodhyd.2019.105355 · Cited by 173
Tagde, P., Tagde, P., Islam, F., Tagde, S., Shah, M., Hussain, Z. D., Rahman, M. H., Najda, A., Alanazi, I. S., Germoush, M. O., et al. (2021) · Molecules · doi:10.3390/molecules26237109 · Cited by 172
“Its structure has three chemical entities: two aromatic ring systems containing o-methoxy phenolic groups connected by a seven-carbon linker consisting of an α, β-unsaturated β-diketone moiety [9].”
BackgroundCurcumin as a clinically-promising anti-cancer agent: pharmacokinetics and drug interactions
Adiwidjaja, J., McLachlan, A. J., & Boddy, A. V. (2017) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1080/17425255.2017.1360279 · Cited by 173
“A recent perspective article in the Journal of Medicinal Chemistry [17] has cast doubt on the relevance of curcumin as a significant component in the therapeutic application of turmeric or curcuminoid extracts.”
BackgroundZeng, L., Yang, T., Yang, K., Yu, G., Li, J., Wang, X., & Chen, H. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.891822 · Cited by 206
In silico polypharmacology of natural products
Fang, J., Liu, C., Wang, Q., Lin, P., & Cheng, F. (2017) · Briefings in Bioinformatics · doi:10.1093/bib/bbx045 · Cited by 199
Antibiofilm and Antivirulence Efficacies of Flavonoids and Curcumin Against Acinetobacter baumannii
Raorane, C. J., Lee, J.-H., Kim, Y.-G., Rajasekharan, S. K., García-Contreras, R., & Lee, J. (2019) · Frontiers in Microbiology · doi:10.3389/fmicb.2019.00990 · Cited by 162
“Curcumin is an unstable, reactive, nonbioavailable compound (Nelson et al., 2017) while it is an established therapeutic”
BackgroundEl‐Saadony, M. T., Saad, A. M., Mohammed, D. M., Alkafaas, S. S., Ghosh, S. B., Negm, S. H., Salem, H. M., Fahmy, M. A., Mosa, W. F. A., Ibrahim, E. H., et al. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1603018 · Cited by 185
“These characteristics restrict its functional ef fi cacy, rendering less than 2% of curcumin bioavailable to the body and limiting its clinical use (71, 90 – 92).”
InfluentialCurcumin analogues and their hybrid molecules as multifunctional drugs
Noureddin, S. A., El-Shishtawy, R. M., & Al-Footy, K. O. (2019) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2019.111631 · Cited by 158
Anti‐microbial activity of curcumin nanoformulations: New trends and future perspectives
Sharifi, S., Fathi, N., Memar, M. Y., Hosseiniyan Khatibi, S. M., Khalilov, R., Negahdari, R., Zununi Vahed, S., & Maleki Dizaj, S. (2020) · Phytotherapy Research · doi:10.1002/ptr.6658 · Cited by 158
Drug repurposing: Misconceptions, challenges, and opportunities for academic researchers
Begley, C. G., Ashton, M. R., Baell, J. B., Bettess, M. D., Brown, M. P., Carter, B. A., Charman, W. N., Davis, C., Fisher, S., Frazer, I. H., et al. (2021) · Science Translational Medicine · doi:10.1126/scitranslmed.abd5524 · Cited by 172
Bolat, Z. B., İşlek, Z., Demir, B. N., Yılmaz, E. N., Şahin, F., & Üçışık, M. H. (2020) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2020.00050 · Cited by 170
Siddiqui, F. A., Prakasam, G., Chattopadhyay, S., Rehman, A. U., Padder, R. A., Ansari, M. A., Irshad, R., Mangalhara, K. C., Bamezai, R. N. K., Husain, M., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-25524-3 · Cited by 173
Macrophage-based nanotherapeutic strategies in ulcerative colitis
Zhang, J., Zhao, Y., Hou, T., Zeng, H., Kalambhe, D., Wang, B., Shen, X., & Huang, Y. (2020) · Journal of Controlled Release · doi:10.1016/j.jconrel.2020.01.047 · Cited by 160
Salehi, B., Lopez-Jornet, P., Pons-Fuster López, E., Calina, D., Sharifi-Rad, M., Ramírez-Alarcón, K., Forman, K., Fernández, M., Martorell, M., Setzer, W., et al. (2019) · Biomolecules · doi:10.3390/biom9030106 · Cited by 155
Curcumin-Based Nanoformulations: A Promising Adjuvant towards Cancer Treatment
Ghoran, S. H., Calcaterra, A., Abbasi, M., Taktaz, F., Nieselt, K., & Babaei, E. (2022) · Molecules · doi:10.3390/molecules27165236 · Cited by 161
“The chemical structure of curcumin, known as (1E,6E)-1,7-bis(4-hydroxy-methoxyphenyl)1,6-heptadiene-3,5-dione, consists of two aromatic ring structures containing hydroxy and methoxy groups, which are linked via a seven-carbon-containing chain of a moiety of α,βunsaturated β-diketone (Figure 1) [26,27].”
BackgroundCurcumin: New Insights into an Ancient Ingredient against Cancer
Willenbacher, E., Khan, S., Mujica, S., Trapani, D., Hussain, S., Wolf, D., Willenbacher, W., Spizzo, G., & Seeber, A. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20081808 · Cited by 148
Curcumin: pharmaceutical solids as a platform to improve solubility and bioavailability
Suresh, K., & Nangia, A. K. (2018) · CrystEngComm · doi:10.1039/c8ce00469b · Cited by 160
The Essential Medicinal Chemistry of Cannabidiol (CBD)
Nelson, K. M., Bisson, J. I., Singh, G., Graham, J. G., Chen, S., Friesen, J. B., Dahlin, J. L., Niemitz, M., Walters, M. A., & Pauli, G. F. (2020) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.0c00724 · Cited by 166
Self-citationCurcumin: An epigenetic regulator and its application in cancer
Ming, T., Tao, Q., Tang, S., Zhao, H., Yang, H., Liu, M., Ren, S., & Xu, H. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.113956 · Cited by 162
Obstacles against the Marketing of Curcumin as a Drug
Hassanzadeh, K., Buccarello, L., Dragotto, J., Mohammadi, A., Corbo, M., & Feligioni, M. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21186619 · Cited by 157
Signal pathways in the treatment of Alzheimer’s disease with traditional Chinese medicine
Ding, M.-R., Qu, Y.-J., Hu, B., & An, H. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.113208 · Cited by 159
The Role of Curcumin in the Modulation of Ageing
Bielak-Zmijewska, A., Grabowska, W., Ciolko, A., Bojko, A., Mosieniak, G., Bijoch, Ł., & Sikora, E. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20051239 · Cited by 140
“Curcumin, like other polyphenols, possesses pleiotropic activity (curcumin belongs to the PAINS, pan-assay interference compounds), which is considered as a serious disadvantage of natural compounds [62].”
BackgroundCurcumin encapsulation in functional PLGA nanoparticles: A promising strategy for cancer therapies
Feltrin, F. D. S., Agner, T., Sayer, C., & Lona, L. M. F. (2021) · Advances in Colloid and Interface Science · doi:10.1016/j.cis.2021.102582 · Cited by 152
Neurogenesis in the aging brain
Apple, D. M., Fonseca, R. S., & Kokovay, E. (2017) · Biochemical Pharmacology · doi:10.1016/j.bcp.2017.06.116 · Cited by 154
“tivity when it, in fact, does not [117,118].”
Zhang, H. A., & Kitts, D. D. (2021) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-021-04201-6 · Cited by 159
Ciuca, M. D., & Racoviţă, R. C. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24108874 · Cited by 154
“It is also a natural spice used as a colorant in curry, mustard [13], salads, pasta, yoghurt, cheese, and baked goods [14].”
BackgroundPrati, F., Bottegoni, G., Bolognesi, M. L., & Cavalli, A. (2018) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.7b00393 · Cited by 131
Pushpalatha, R., Selvamuthukumar, S., & Kilimozhi, D. (2018) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2018.03.004 · Cited by 143
Natural Antioxidant Compounds as Potential Pharmaceutical Tools against Neurodegenerative Diseases
Marino, A., Battaglini, M., Moles, N., & Ciofani, G. (2022) · ACS Omega · doi:10.1021/acsomega.2c03291 · Cited by 144
Gómez‐Mascaraque, L. G., Sípoli, C. C., de la Torre, L. G., & López‐Rubio, A. (2017) · Food Chemistry · doi:10.1016/j.foodchem.2017.04.133 · Cited by 135
Some Natural Photosensitizers and Their Medicinal Properties for Use in Photodynamic Therapy
Kubrak, T. P., Kołodziej, P., Sawicki, J., Mazur, A., Koziorowska, K., & Aebisher, D. (2022) · Molecules · doi:10.3390/molecules27041192 · Cited by 122
Chemoproteomics and Chemical Probes for Target Discovery
Drewes, G., & Knapp, S. (2018) · Trends in Biotechnology · doi:10.1016/j.tibtech.2018.06.008 · Cited by 132
Jin, T., Song, Z., Weng, J., & Fantus, I. G. (2018) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00285.2017 · Cited by 127
“The investigation of curcuminoids, which comprise 1–6% of the plant extract and consist of three related compounds, namely, curcumin (60–70%), 3,dimethoxy curcumin (20–27%), and 4, bisdemethoxy curcumin (10– 15%), has increased dramatically (32, 42).”
BackgroundInfluentialReductive metabolites of curcumin and their therapeutic effects
Pandey, A., Chaturvedi, M., Mishra, S., Kumar, P., Somvanshi, P., & Chaturvedi, R. (2020) · Heliyon · doi:10.1016/j.heliyon.2020.e05469 · Cited by 138
“However, this still needs to be adequately validated [13, 22, 23, 24, 25, 26].”
BackgroundKrajka‐Kuźniak, V., & Baer‐Dubowska, W. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22158223 · Cited by 145
“The reason may be low bioavailability and stability along with high reactivity of this phytochemical [50].”
BackgroundJasial, S., Hu, Y., & Bajorath, J. (2017) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.7b00154 · Cited by 128
Azzini, E., Peña‐Corona, S. I., Hernández‐Parra, H., Chandran, D., Saleena, L. A. K., Sawikr, Y., Peluso, I., Dhumal, S., Kumar, M., Leyva‐Gómez, G., et al. (2024) · Phytotherapy Research · doi:10.1002/ptr.8200 · Cited by 133
“Curcumin's toxicity is minimal, even at substantial doses (up to 12 g in people) (Nelson et al., 2017).”
BackgroundRole of curcumin in the management of pathological pain
Sun, J., Chen, F., Braun, C., Zhou, Y., Rittner, H. L., Tian, Y., Cai, X.-Y., & Ye, D. (2018) · Phytomedicine · doi:10.1016/j.phymed.2018.04.045 · Cited by 133
Mahmud, S., Uddin, M. A. R., Paul, G. K., Shimu, M. S. S., Islam, S., Rahman, M. E., Islam, A., Islam, M. S., Promi, M. M., Emran, T. B., et al. (2020) · Briefings in Bioinformatics · doi:10.1093/bib/bbaa428 · Cited by 128
“The first candidate curcumin surrounds curcumin moiety consists of feruloyl chromophores which are joined by a methyl group [56].”
BackgroundCurcumin Supplementation and Human Disease: A Scoping Review of Clinical Trials
Panknin, T., Howe, C. L., Hauer, M., Bucchireddigari, B., Rossi, A., & Funk, J. L. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24054476 · Cited by 134
“Questions remain as to whether these benefits extend to humans [15,16].”
BackgroundInfluentialNatural products as LSD1 inhibitors for cancer therapy
Fang, Y., Yang, C., Yu, Z., Li, X., Mu, Q., Liao, G., & Yu, B. (2020) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2020.06.007 · Cited by 128
Metadata
- Authors
- Nelson, K. M., Dahlin, J. L., Bisson, J., Graham, J., Pauli, G. F., & Walters, M. A.
- Affiliations
- University of Minnesota (US)
- Brigham and Women's Hospital (US)
- University of Illinois Chicago (US)
- Corresponding author
- Walters, Michael A.
- ORCID
- Venue
- Journal of Medicinal Chemistry
- Publisher
- American Chemical Society (ACS)
- Published
- 2017-01-11
- Volume
- 60
- Issue
- 5
- Pages
- 1620-1637
- ISSN
- 0022-2623 (ISSN-L)
- 1520-4804
- PMC
- PMC5346970
- OpenAlex
- W2579340176
- Cited by
- 1,956
- References
- 153
- Citations by year
- 2026: 177 · 2025: 213 · 2024: 204 · 2023: 233 · 2022: 244 · 2021: 257 · 2020: 211 · 2019: 183 · 2018: 157 · 2017: 75
- FWCI
- 11.16
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Locations
- Journal of Medicinal Chemistry (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Figshare (submittedVersion, cc-by-nc-nd)
- University of Illinois Chicago
- Funders
- Office of Dietary Supplements (U41AT008706)
- National Center for Complementary and Integrative Health (U41AT008706)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Medicine › Curcumin's Biomedical Applications
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Drug Discovery › Bioactive natural compounds
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Saffron Plant Research Studies
- Keywords
- curcumin, curcuminoids, turmeric, medicinal chemistry, PAINS, IMPS, bioavailability, clinical trials
- MeSH terms
- Animals, Chemistry, Pharmaceutical, Curcumin, Humans
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.